Acta Pharmaceuticals
Boston, US · Founded 2022
Biotech
Founders & leadership
GA
George AlexExecutive Officer, Director
TP
Thierry PorteDirector
RT
Rudolph TanziDirector
Reported raises · per SEC filings
Form D private placements▶$13.4MraisedApr 2024 · 29 investors · PharmaceuticalsRule 506(b)
▶$13.4MraisedApr 2024 · 29 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George AlexExecutive Officer, Director
- Thierry PorteDirector
- Rudolph TanziDirector
- Offering amount
- $17.5M
- Amount sold
- $13.4M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.